PCM
DXCM icon

Prelude Capital Management’s DexCom DXCM Stock Holding History

Prelude Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-400
Closed -$15K – 1988
2019
Q3 		$15K Hold
400
– – ﹤0.01% 1433
2019
Q2 		$15K Buy
+400
New +$12.6K ﹤0.01% 1330

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Prelude Capital Management's DXCM Position: Q1 2026 in Review

Prelude Capital Management reduced its DexCom (DXCM) stake by 66% in Q1 2026, selling an estimated $753K and leaving 5,543 shares worth $348K. The position accounts for 0.03% of the portfolio, ranked #649.

Prelude Capital Management first reported a position in DXCM in Q4 2014 and has held it in 25 quarters since. The position peaked at $2.71M in Q1 2022. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Prelude Capital Management held 5,543 shares of DexCom worth $348K as of Q1 2026.
  • Prelude Capital Management sold 10,818 DexCom shares in Q1 2026, an estimated $753K.
  • DexCom made up 0.03% of Prelude Capital Management's portfolio in Q1 2026, its #649 holding.
  • Prelude Capital Management first reported a position in DexCom in Q4 2014 and has held it in 25 quarters since.
  • Prelude Capital Management's DexCom position peaked at $2.71M in Q1 2022.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.